Senti Biosciences (SNTI) Invested Capital (2021 - 2025)
Senti Biosciences (SNTI) has 5 years of Invested Capital data on record, last reported at $8.1 million in Q3 2025.
- For Q3 2025, Invested Capital fell 49.29% year-over-year to $8.1 million; the TTM value through Sep 2025 reached $8.1 million, down 49.29%, while the annual FY2024 figure was $25.6 million, 61.67% down from the prior year.
- Invested Capital reached $8.1 million in Q3 2025 per SNTI's latest filing, down from $24.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $154.3 million in Q2 2022 and bottomed at -$121.8 million in Q1 2022.
- Average Invested Capital over 5 years is $25.8 million, with a median of $37.9 million recorded in 2025.
- Peak YoY movement for Invested Capital: skyrocketed 270.2% in 2022, then plummeted 80.69% in 2024.
- A 5-year view of Invested Capital shows it stood at -$111.5 million in 2021, then soared by 214.18% to $127.3 million in 2022, then plummeted by 47.42% to $66.9 million in 2023, then crashed by 61.67% to $25.6 million in 2024, then tumbled by 68.34% to $8.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Invested Capital were $8.1 million in Q3 2025, $24.7 million in Q2 2025, and $37.9 million in Q1 2025.